RxDoctor Payments Data

Marion Hautea, MD

Family Medicine · Rogers City, MINPI 1962455972

Payments from drug & device makers

$285in general payments, 2019–2025

Across 22 payments — averaging $12.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$87
  • Novo Nordisk$49
  • Exact Sciences$43
  • Sunovion Pharmaceuticals Inc.$37
  • AstraZeneca$31
  • Novartis$15
  • plus $24 from 2 others

What the payments were for

  • Food & beverage$27295%
  • Education$135%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$285 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$2,090
Medicare patients
111
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban155$151,782
FarxigaDapagliflozin Propanediol83$93,857
Humira(Cf)Adalimumab11$91,381
Enbrel SureclickEtanercept11$85,862
OzempicSemaglutide63$75,260
Bydureon BciseExenatide Microspheres57$55,523
JanuviaSitagliptin Phosphate40$51,978
JardianceEmpagliflozin43$49,515
TrulicityDulaglutide46$42,365
XareltoRivaroxaban46$35,955
MyrbetriqMirabegron47$28,850
Breo ElliptaFluticasone/Vilanterol29$14,430
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,553
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl40$13,100
InvokanaCanagliflozin15$8,294

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$31$93,85783 claims
Novo NordiskOzempic$49$75,26063 claims
Lilly USA, LLCTrulicity$11$42,36546 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Rogers City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →